Phibro Animal Health (PAHC) Revenue Growth (3y) (2015 - 2026)

Phibro Animal Health (PAHC) Revenue Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 2.84%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 4.19%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 15.52%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 14.49%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 24.66%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 2.94%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -48.41%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 7.85%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 47.17%
10 Phibro Animal Health 1.26 Bn 1.19 Bn 125.68 Mn 16.01%

Historic Data

Download Data
DateValue
Mar 31, 2026 16.01%
Dec 31, 2025 15.19%
Sep 30, 2025 16.10%
Jun 30, 2025 14.05%
Mar 31, 2025 13.23%
Dec 31, 2024 9.94%
Sep 30, 2024 6.65%
Jun 30, 2024 7.44%
Mar 31, 2024 7.53%
Dec 31, 2023 6.63%
Sep 30, 2023 5.83%
Jun 30, 2023 11.12%
Mar 31, 2023 5.25%
Dec 31, 2022 4.56%
Sep 30, 2022 7.02%
Jun 30, 2022 7.78%
Mar 31, 2022 5.21%
Dec 31, 2021 2.17%
Sep 30, 2021 2.36%
Jun 30, 2021 1.32%